Market Trends of Bovine Mastitis Industry
This section covers the major market trends shaping the Bovine Mastitis Market according to our research experts:
Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period
The clinical mastitis segment is expected to hold a major share due to the high prevalence of clinical mastitis and the growing demand for effective therapeutics. According to a study published in the MDPI Journal in May 2021, the incidence of clinical mastitis in Southern Ethiopia was found to be 9%, 10%, and 10% in cows, camels, and goats, respectively, in 2020. Thus, the high prevalence of clinical mastitis is expected to drive the demand for effective therapeutics, thereby driving the growth of the segment.
The increasing R&D activities for the treatment of clinical mastitis are also expected to contribute to the growth of the segment. For instance, in January 2021, the Institute of Global Food Security at Queen's University launched a research project to tackle bovine clinical mastitis and reduce the broad spectrum of antibiotics in dairy cattle. This project was launched in partnership with AgriSearch and the Agri-Food and Biosciences Institutes (AFBI).
Thus, such factors are expected to contribute to the growth of the segment over the forecast period.
Asia-Pacific is Expected to Hold a Significant Share of the Market During the Forecast Period
Asia-Pacific is expected to hold a major share of the bovine mastitis market over the forecast period without significant fluctuations due to the strong adoption of intra-mammary infusion products for the treatment and the presence of leading players in the region.
The increasing incidence of bovine mastitis in the region is also expected to drive the growth of the market over the forecast period. For instance, according to the data published by Wageningen University and Research in 2022, the prevalence of subclinical mastitis among the cattle population in Sri Lanka, Bangladesh, India, and Pakistan ranged from about 20% to 80%. Such prevalence of bovine mastitis in Asia-Pacific is expected to drive the growth of the market in the region.
The adoption of advanced technologies in the region to manage bovine mastitis is also expected to contribute to the market's growth. For instance, in August 2021, Dairy Australia, Coles, Food Agility CRC, University of Sydney, University Technology Sydney, and Charles Sturt University collaborated to reduce the use of antibiotics in the milk supply chain and improve the health and management of dairy cows with mastitis. These organizations used the clinical mastitis decision support tool project, an AI-powered tool to manage clinical mastitis. Such developments are expected to contribute to the growth of the market in Asia-Pacific over the forecast period.
